Search
Displaying 391–400 of 1077 results
-
My name is Terry Super. As a Professional Engineer, my career was defined by technical and left-brained stuff. Today, I’m semi-retired and have been relaxing by doing some creative and right-brained stuff - oil painting.
-
Erin Halford is a visual artist, writer, and educator who lives in the greater Los Angeles area. She graduated with her MFA in Studio from the School of the Art Institute of Chicago in 2017, and she has exhibited her art throughout the United States, as well as in the United Kingdom and in Japan. Schalk’s artwork and writing have also been published in a variety of literary journals.
-
Colin was born in the small Western New York Community of Jamestown. His emersion into the arts started naturally, his mother was a designer and his father an art and antiques collector.
-
Alley Morgan is from Dayton, Ohio. She has an inexhaustible love of wildlife and art. By combining those interests, she specializes in creating fun and goofy animals characters with personality and attitude.
-
“Eye of the Beholder” was initiated by two artists — both affected by retinal disease, and who are very well aware of the significance of such a contribution. For some, our artwork is an important source of income; for all, it is a deeply personal pursuit.
-
RD Fund Participates in a €75 Million Series B for SparingVision
In the PressProceeds to fund first, in-human trials of breakthrough gene-agnostic therapy products and advance CRISPR-based genome editing portfolio.
-
Foundation Fighting Blindness Makes Key Appointments to Leadership Team
Foundation NewsSeveral executives promoted to continue the advancement of the Foundation’s notable research and philanthropic efforts.
-
Youngest U.S. Blind Golfer Heading to the 2022 Vision Cup
Beacon StoriesTyler Cashman is one of six U.S. team members that have been selected to participate in the upcoming 2022 Vision Cup, an international golf competition for the blind hosted by the United States Blind Golf Association (USBGA), taking place on September 19-22, 2022.
-
Iveric Bio’s Zimura for Advanced Dry AMD Meets Endpoint in Second Phase 3 Clinical Trial
Research NewsThe company plans to seek FDA approval for the emerging therapy in first quarter of 2023
-
Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
Research NewsThe company’s drug is designed to reduce accumulation of toxins that cause vision loss.
